HRT Financial’s AstraZeneca AZN Stock Holding History

HRT Financial’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$265K	Buy	+1,400	New	+$263K	﹤0.01%	3177

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HRT Financial's AZN Position: Q2 2026 in Review

HRT Financial reduced its AstraZeneca (AZN) stake by 46% in Q2 2026, selling an estimated $1.65M and leaving 10,334 shares worth $1.96M. The position accounts for ﹤0.01% of the portfolio, ranked #1768.

HRT Financial first reported a position in AZN in Q3 2017 and has held it in 19 quarters since. The position peaked at $17.1M in Q1 2025. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

HRT Financial held 10,334 shares of AstraZeneca worth $1.96M as of Q2 2026.
HRT Financial sold 8,750 AstraZeneca shares in Q2 2026, an estimated $1.65M.
AstraZeneca made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #1768 holding.
HRT Financial first reported a position in AstraZeneca in Q3 2017 and has held it in 19 quarters since.
HRT Financial's AstraZeneca position peaked at $17.1M in Q1 2025.
1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.